Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14906279 | 0.84 | TDP1 (0.45) | KMT2A | |
| Water SCHEMBL7533665 | 0.84 | ZDHHC7 (0.45) | GPR84FFAR1ZDHHC7NOD1ACE | |
| SCHEMBL27554867 | 0.83 | ZDHHC7 (0.47) | GPR84FFAR1ZDHHC7NOD1ACE | |
| SCHEMBL27574677 | 0.83 | ZDHHC7 (0.47) | GPR84FFAR1ZDHHC7NOD1ACE | |
| SCHEMBL7739253 | 0.83 | ZDHHC7 (0.47) | GPR84FFAR1ZDHHC7NOD1ACE | |
| SCHEMBL27512521 | 0.83 | ZDHHC7 (0.47) | GPR84FFAR1ZDHHC7NOD1ACE | |
| SCHEMBL27534343 | 0.83 | ZDHHC7 (0.47) | GPR84FFAR1ZDHHC7NOD1ACE | |
| SCHEMBL11332462 | 0.82 | ZDHHC7 (0.46) | ZDHHC7NOD1ACEFAAHKMT2A | |
| SCHEMBL5328117 | 0.81 | GPR84 (0.45) | GPR84FFAR1FFAR4ZDHHC7NOD1 | |
| SCHEMBL11087551 | 0.79 | KMT2A (0.49) | GPR84FFAR1FFAR4NOD1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130158021-A1 | AMINO ACID-, PEPTIDE-AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130158021-A1 | AMINO ACID-, PEPTIDE-AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF | APLNR, NPPA, ARGLU1 | GPR84 225/4885FFAR1 129/4885FFAR4 155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.